GADD45B and Miyoshi myopathy: Moreover, MM patients exhibiting high levels of GADD45β expression had reduced progression-free survival (PFS) and overall survival (OS) rates compared to patients expressing lower GADD45β levels, demonstrating that elevated GADD45β expression denotes more aggressive disease and a has less favourable clinical outcome.